Wedbush Upgrades Nu Skin To Outperform

According to Wedbush, Nu Skin Enterprises NUS price target is raised to $48. Wedbush said that it is upgrading NUS to Outperform. “Given potential multiple expansion as expected success of major upcoming product launches should further solidify Nu Skin's reputation as a successful innovator in the global direct-selling industry, we believe shares of NUS should trade at a 20% premium to the peer group average.” Nu Skin Enterprises closed yesterday at $41.47.